tiprankstipranks
Trending News
More News >

Sichuan Kelun-Biotech to Announce Annual Results on March 24, 2025

Story Highlights
Sichuan Kelun-Biotech to Announce Annual Results on March 24, 2025

Confident Investing Starts Here:

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( (HK:6990) ) has issued an announcement.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has announced a board meeting scheduled for March 24, 2025, to approve and release the company’s annual results for the year ending December 31, 2024. Following the announcement, a conference call with management will be held to discuss the results, indicating the company’s commitment to transparency and stakeholder engagement.

More about Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the biopharmaceutical industry. The company focuses on developing and manufacturing biopharmaceutical products, with a market presence in Hong Kong.

YTD Price Performance: 49.91%

Average Trading Volume: 339,400

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$54.55B

Find detailed analytics on 6990 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App